
Infantile hemangiomas (IHs), the most common vascular tumor of infancy, occur in about 10% of infants. Most lesions proliferate and then involute without any complications. Most common reported complication is ulceration occurring in16% of IHs. Currently, modalities like oral propranolol, provided better therapeutic options and side effect profile as compare to systemic corticosteroids. Few cases of propranolol resistant IH have been reported in which adjunctive modalities like topical timolol or intralesional corticosteroids can be tried.